Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-198-9 | CAS number: 7446-14-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- experimental study
- Adequacy of study:
- other information
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Acceptable, well-documented publication which meets basic scientific principles
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 1 981
Materials and methods
- Objective of study:
- distribution
- Principles of method if other than guideline:
- Eigth-month-old dogs maintained on a high-fat-low-calcium diet were administred a mixture of lead chloride, lead bromide and lead sulphate for a prolonged periods at 4 different dose levels. Radiological investigations were made.
- GLP compliance:
- not specified
Test material
- Reference substance name:
- Automatically generated during migration to IUCLID 6, no data available
- IUPAC Name:
- Automatically generated during migration to IUCLID 6, no data available
- Details on test material:
- The lead salt mixture consisited of lead chloride, lead bromide and lead sulphate in the proportions 1:1:2 respectively. These lead compounds in approximately similar proportions are the major by-products in the exhaust emission of internal combustion engines which utilize leaded petrol (bloom, 1979, pers. comm.). All dogs were weighed once a week and the dose of lead salt mixture was calculated.
Constituent 1
Test animals
- Species:
- dog
- Strain:
- other: Kelpie-cross
- Sex:
- male/female
Administration / exposure
- Route of administration:
- oral: capsule
- Vehicle:
- other: gelatin
- Duration and frequency of treatment / exposure:
- From 14 to 155 days
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 5, 15, 30 and 60 mg/kg (bw)
- No. of animals per sex per dose / concentration:
- 0, 5,15, 30 mg/kg (bw) : 2 dogs
60 mg/kg (bw) : 3 dogs - Control animals:
- yes
Results and discussion
- Preliminary studies:
- All the dogs on lead treatment began losing weight a very short time of the commencement of the experiment. The dogs on the lowest dose maintained their weight at the pretreatment levels for one week but then gradually lost weight.
Main ADME results
- Type:
- distribution
Toxicokinetic / pharmacokinetic studies
- Details on absorption:
- In the higher dose groups 3 and 5, blood lead increased to over 200µg/dl within 3 days. The levels then dropped markedly for the next 2 weeks and then gradually increased again. In group 4 (controls), the blood level increased slightly and remained above 35µg/dl in dog H182 for approximately 9 weeks.
- Details on distribution in tissues:
- Tissues from the dogs administered lead showed higher levels of lead than did the tissues of the control dogs. Generally the highest lead levels were seen in the distal radius, followed by the lumbar vertebra, the bones of the calvarium, liver and kidney, cerebrum and spinal cord.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): bioaccumulation potential cannot be judged based on study results
In the present experiment, it is probable that a high proportion of the administred lead was absorbed from the intestines and this may have contributed to negative radiological findings in a large porportion of the abdominal radiographs.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.